[go: up one dir, main page]

CO6870003A2 - Vacunas bovinas y métodos - Google Patents

Vacunas bovinas y métodos

Info

Publication number
CO6870003A2
CO6870003A2 CO13268129A CO13268129A CO6870003A2 CO 6870003 A2 CO6870003 A2 CO 6870003A2 CO 13268129 A CO13268129 A CO 13268129A CO 13268129 A CO13268129 A CO 13268129A CO 6870003 A2 CO6870003 A2 CO 6870003A2
Authority
CO
Colombia
Prior art keywords
methods
bovine vaccines
vaccines
bovine
Prior art date
Application number
CO13268129A
Other languages
English (en)
Inventor
Eric Springer
Original Assignee
Novartis Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novartis Ag filed Critical Novartis Ag
Publication of CO6870003A2 publication Critical patent/CO6870003A2/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/0225—Spirochetes, e.g. Treponema, Leptospira, Borrelia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/102—Pasteurellales, e.g. Actinobacillus, Pasteurella; Haemophilus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/155—Paramyxoviridae, e.g. parainfluenza virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/521—Bacterial cells; Fungal cells; Protozoal cells inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Immunology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pulmonology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
CO13268129A 2011-06-10 2013-11-14 Vacunas bovinas y métodos CO6870003A2 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US201161495591P 2011-06-10 2011-06-10

Publications (1)

Publication Number Publication Date
CO6870003A2 true CO6870003A2 (es) 2014-02-20

Family

ID=47296754

Family Applications (1)

Application Number Title Priority Date Filing Date
CO13268129A CO6870003A2 (es) 2011-06-10 2013-11-14 Vacunas bovinas y métodos

Country Status (6)

Country Link
US (1) US9364527B2 (es)
CA (1) CA2836805C (es)
CO (1) CO6870003A2 (es)
MX (1) MX345704B (es)
PE (1) PE20140576A1 (es)
WO (1) WO2012170753A2 (es)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2807552A1 (en) 2010-08-06 2012-02-09 Moderna Therapeutics, Inc. Engineered nucleic acids and methods of use thereof
PT3590949T (pt) 2010-10-01 2022-08-02 Modernatx Inc Ácidos ribonucleicos contendo n1-metilpseudouracilos e suas utilizações
JP2014511687A (ja) 2011-03-31 2014-05-19 モデルナ セラピューティクス インコーポレイテッド 工学操作された核酸の送達および製剤
SG11201402666WA (en) 2011-12-16 2014-10-30 Moderna Therapeutics Inc Modified nucleoside, nucleotide, and nucleic acid compositions
US9572897B2 (en) 2012-04-02 2017-02-21 Modernatx, Inc. Modified polynucleotides for the production of cytoplasmic and cytoskeletal proteins
EP2847329A4 (en) 2012-04-02 2016-08-10 Moderna Therapeutics Inc MODIFIED POLYNUCLEOTIDES FOR THE PREPARATION OF CYTOPLASMA AND CYTOSCELETTE PROTEINS
US9283287B2 (en) 2012-04-02 2016-03-15 Moderna Therapeutics, Inc. Modified polynucleotides for the production of nuclear proteins
US9878056B2 (en) 2012-04-02 2018-01-30 Modernatx, Inc. Modified polynucleotides for the production of cosmetic proteins and peptides
WO2014028429A2 (en) 2012-08-14 2014-02-20 Moderna Therapeutics, Inc. Enzymes and polymerases for the synthesis of rna
RS63237B1 (sr) 2012-11-26 2022-06-30 Modernatx Inc Terminalno modifikovana rnk
US20160024181A1 (en) 2013-03-13 2016-01-28 Moderna Therapeutics, Inc. Long-lived polynucleotide molecules
WO2014152211A1 (en) 2013-03-14 2014-09-25 Moderna Therapeutics, Inc. Formulation and delivery of modified nucleoside, nucleotide, and nucleic acid compositions
EP3052106A4 (en) 2013-09-30 2017-07-19 ModernaTX, Inc. Polynucleotides encoding immune modulating polypeptides
ES2810701T5 (es) 2015-10-05 2024-07-11 Modernatx Inc Procedimientos para la administración terapéutica de medicamentos de ácido ribonucleico mensajero
DK3407734T3 (da) 2016-01-25 2023-05-01 Signify North America Corp Biosikkerhedssystem til en landbrugsbygning

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ501213A (en) * 1998-12-22 2001-09-28 Pfizer Prod Inc Isolated leptospira membrane kinase, membrane permease, membrane mannosyltransferase and endoflagellin proteins for preventing leptospirosis
NZ538394A (en) * 2002-08-26 2008-06-30 Pfizer Prod Inc Vaccine for respiratory and reproductive system infections in cattles
US7563449B2 (en) * 2003-04-21 2009-07-21 Pfizer Inc, Methods for reducing cattle reproductive diseases
US20090068223A1 (en) 2005-11-15 2009-03-12 Boehringer Ingelheim Vetmedica, Inc. Combination vaccine comprising an attenuated bovine viral diarrhea virus
LT3056214T (lt) 2008-06-27 2019-06-10 Zoetis Services Llc Naujos adjuvantų kompozicijos

Also Published As

Publication number Publication date
US20140105930A1 (en) 2014-04-17
MX345704B (es) 2017-02-10
CA2836805C (en) 2023-03-07
PE20140576A1 (es) 2014-05-24
MX2013014485A (es) 2014-03-21
WO2012170753A3 (en) 2014-05-08
CA2836805A1 (en) 2012-12-13
US9364527B2 (en) 2016-06-14
WO2012170753A2 (en) 2012-12-13

Similar Documents

Publication Publication Date Title
IL272539B (en) Compositions and methods for immunotherapy
CO6870003A2 (es) Vacunas bovinas y métodos
CO6930343A2 (es) Conjunto conntenedor y método asociado
BR112014000238A2 (pt) método e artigo
DK3321287T3 (da) Fusionsproteiner og kombinationsvacciner
EP2772078A4 (en) SYSTEMS AND METHODS FOR TWO-FACTOR AUTHENTICATION
DK2794654T3 (da) Anti-phf-tau-antistoffer og deres anvendelser
HK1199694A1 (zh) 益生菌組合物和方法
DK2850202T3 (da) Fremgangsmåder og grupper
BR112014012137A2 (pt) anticorpos anti-fgfr2 e suas utilizações
BR112013001592A2 (pt) artigo e método
EP2753345A4 (en) POLYPEPTIDIMPFSTOFF
HK1204261A1 (zh) 免疫原性 肽及其使用方法
PL2739268T3 (pl) Sposób i formulacja do inhalacji
BR112014010450A2 (pt) composição e método
FI20116190L (fi) Hissijärjestely ja menetelmä
BR112013010847A2 (pt) artigo e método
ZA201400562B (en) Axmi205 variant proteins and methods for their use
EP2767568A4 (en) SUSPENSION AND METHOD OF POLISHING
SMT201600082B (it) Vaccino pcsk9
BR112013029674A2 (pt) dispositivo para manuseio e método
BR112013022411A2 (pt) artigo absorvente e método para preparar um artigo absorvente
BR112013022766A2 (pt) método de administração de d-pirfenidona e kit
EP2755680A4 (en) PARTICULATE VACCINE FORMULATIONS
BR112013020287A2 (pt) projetor e método de autenticação